Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 28: | Line 28: | ||
=====mTOR inhibitor===== | =====mTOR inhibitor===== | ||
* Rapamune - Generic: Sirolimus ([[Rapamycin]]) | * Rapamune - Generic: Sirolimus ([[Rapamycin]]) | ||
| - | * Everolimus | + | * Afinitor - Generic: Everolimus |
| - | * Temsirolimus | + | * Torisel - Generic: Temsirolimus |
=====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor===== | =====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor===== | ||
* [[Gleevec]] - Generic: [[Imatinib]] | * [[Gleevec]] - Generic: [[Imatinib]] | ||
Revision as of 15:33, 17 July 2019
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor ModulatormTOR inhibitor
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
